Publicacións nas que colabora con MAR CARRIÓN CABALLO (27)

2024

  1. Vasoactive intestinal peptide exerts an osteoinductive effect in human mesenchymal stem cells

    BioFactors

2022

  1. Human CD4+CD45RA+ T Cells Behavior after In Vitro Activation: Modulatory Role of Vasoactive Intestinal Peptide

    International Journal of Molecular Sciences, Vol. 23, Núm. 4

2021

  1. Proteomic analysis of synovial fibroblasts and articular chondrocytes co-cultures reveals valuable vip-modulated inflammatory and degradative proteins in osteoarthritis

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

  2. The neuropeptide vip limits human osteoclastogenesis: Clinical associations with bone metabolism markers in patients with early arthritis

    Biomedicines, Vol. 9, Núm. 12

2020

  1. A clinical approach for the use of VIP axis in inflammatory and autoimmune diseases

    International Journal of Molecular Sciences, Vol. 21, Núm. 1

  2. Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence

    Cells, Vol. 9, Núm. 12

  3. Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients

    Scientific Reports, Vol. 9, Núm. 1

  2. An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance

    Frontiers in Endocrinology, Vol. 10

  3. Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin

    Cells, Vol. 9, Núm. 1

  4. Wnt and RUNX2 mediate cartilage breakdown by osteoarthritis synovial fibroblast-derived ADAMTS-7 and -12

    Journal of Cellular and Molecular Medicine, Vol. 23, Núm. 6, pp. 3974-3983

2018

  1. The anti-inflammatory mediator, vasoactive intestinal peptide, modulates the differentiation and function of Th subsets in rheumatoid arthritis

    Journal of Immunology Research, Vol. 2018

2016

  1. VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts

    Journal of Cellular and Molecular Medicine, Vol. 20, Núm. 4, pp. 678-687

  2. VIP impairs acquisition of the macrophage proinflammatory polarization profile

    Journal of Leukocyte Biology, Vol. 100, Núm. 6, pp. 1385-1393

2015

  1. The pathogenic Th profile of human activated memory Th cells in early rheumatoid arthritis can be modulated by VIP

    Journal of Molecular Medicine, Vol. 93, Núm. 4, pp. 457-467

2014

  1. Urokinase plasminogen activator system in synovial fibroblasts from osteoarthritis patients: Modulation by inflammatory mediators and neuropeptides

    Journal of Molecular Neuroscience, Vol. 52, Núm. 1, pp. 18-27

  2. VIP modulates IL-22R1 expression and prevents the contribution of rheumatoid synovial fibroblasts to IL-22-mediated joint destruction

    Journal of Molecular Neuroscience, Vol. 52, Núm. 1, pp. 10-17

  3. Vasoactive Intestinal Peptide Maintains the Nonpathogenic Profile of Human Th17-Polarized Cells

    Journal of Molecular Neuroscience, Vol. 54, Núm. 3, pp. 512-525

2013

  1. IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts

    Rheumatology (United Kingdom), Vol. 52, Núm. 12, pp. 2177-2186

  2. Inflammatory mediators alter interleukin-17 receptor, interleukin-12 and -23 expression in human osteoarthritic and rheumatoid arthritis synovial fibroblasts: Immunomodulation by vasoactive intestinal peptide

    NeuroImmunoModulation, Vol. 20, Núm. 5, pp. 274-284